{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:41:56Z","timestamp":1777470116964,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In this work, we aim to evaluate the association of the genetically proxied effect of metformin on blood pressure (BP) and hypertension through a drug target-based Mendelian randomization (MR) analysis. Thirty-two instrumental variables for five metformin targets (i.e., AMP-activated protein kinase (AMPK), growth differentiation factor 15 (GDF15), mitochondrial glycerol 3 (MG3), mitochondrial complex I (MCI), and glucagon (GCG)) were introduced to the MR analysis on the datasets of hypertension, systolic and diastolic blood pressure (SBP and DBP). The MR analyses demonstrated that the MCI- and MG3-specific metformin\u2019s use would significantly reduce SBP, DBP, and hypertension risk. The meta-analyses showed that the genetically proxied metformin\u2019s use equivalent to a 6.75\u00a0mmol\/mol reduction on HbA1c could decrease both the SBP (beta\u2009=\u2009\u2009\u2212\u20091.05,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and DBP (beta\u2009=\u2009\u2009\u2212\u20090.51,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.096). Furthermore, metformin\u2019s use was also implied to reduce the hypertension risk. The MG3- and MCI-dependent metformin\u2019s effect may play key roles in the anti-hypertension function.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s12265-023-10460-z","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:08:23Z","timestamp":1701086903000},"page":"716-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension\u2019s Risk: a Drug Target-Based Mendelian Randomization Study"],"prefix":"10.1007","volume":"17","author":[{"given":"Junhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-6657","authenticated-orcid":false,"given":"Zenan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of The \u03bc-Biomedical Data Investigation Group (Mu-BioDig)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"10460_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923\u201394.","DOI":"10.1016\/S0140-6736(18)32225-6"},{"issue":"15","key":"10460_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"11","key":"10460_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2337\/diacare.19.11.1185","volume":"19","author":"G Fangh\u00e4nel","year":"1996","unstructured":"Fangh\u00e4nel G, S\u00e1nchez-Reyes L, Trujillo C, Sotres D, Espinosa-Campos J. Metformin\u2019s effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care. 1996;19(11):1185\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"10460_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/apt.16460","volume":"54","author":"N Rittig","year":"2021","unstructured":"Rittig N, Aagaard NK, Villadsen GE, Sandahl TD, Jessen N, Gr\u00f8nbaek H, et al. Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther. 2021;54(3):320\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10460_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/HJH.0000000000001119","volume":"35","author":"L Zhou","year":"2017","unstructured":"Zhou L, Liu H, Wen X, Peng Y, Tian Y, Zhao L. Effects of metformin on blood pressure in nondiabetic patients: a meta-analysis of randomized controlled trials. J Hypertens. 2017;35(1):18\u201326.","journal-title":"J Hypertens"},{"issue":"1","key":"10460_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","volume":"256","author":"MG Wulffel\u00e9","year":"2004","unstructured":"Wulffel\u00e9 MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med. 2004;256(1):1\u201314.","journal-title":"J Intern Med"},{"issue":"11","key":"10460_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1056\/NEJMe1901565","volume":"380","author":"MV Holmes","year":"2019","unstructured":"Holmes MV. Human genetics and drug development. N Engl J Med. 2019;380(11):1076\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"10460_CR8","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/s41467-021-25731-z","volume":"12","author":"M Gordillo-Mara\u00f1\u00f3n","year":"2021","unstructured":"Gordillo-Mara\u00f1\u00f3n M, Zwierzyna M. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nat Commun. 2021;12(1):6120.","journal-title":"Nat Commun"},{"issue":"10","key":"10460_CR9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","volume":"65","author":"J Zheng","year":"2022","unstructured":"Zheng J, Xu M, Walker V, Yuan J, Korologou-Linden R, Robinson J, et al. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: a Mendelian randomisation study. Diabetologia. 2022;65(10):1664\u201375.","journal-title":"Diabetologia."},{"key":"10460_CR10","doi-asserted-by":"crossref","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u201330.","DOI":"10.1126\/science.aaz1776"},{"issue":"9","key":"10460_CR11","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"10","key":"10460_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331.","journal-title":"Nat Genet."},{"issue":"7726","key":"10460_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature."},{"issue":"7944","key":"10460_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature."},{"key":"10460_CR15","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.","journal-title":"eLife."},{"issue":"1","key":"10460_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","volume":"51","author":"A Giri","year":"2019","unstructured":"Giri A, Hellwege JN, Keaton JM, Park J, Qiu C, Warren HR, et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet. 2019;51(1):51\u201362.","journal-title":"Nat Genet"},{"issue":"5","key":"10460_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet."},{"issue":"4","key":"10460_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"10460_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1291\/hypres.19.37","volume":"19","author":"I Kosegawa","year":"1996","unstructured":"Kosegawa I, Katayama S, Kikuchi C, Kashiwabara H, Negishi K, Ishii J, et al. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertens Res: Off J Japan Soc Hypertens. 1996;19(1):37\u201341.","journal-title":"Hypertens Res: Off J Japan Soc Hypertens"},{"issue":"22","key":"10460_CR20","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/j.lfs.2005.10.020","volume":"78","author":"JB Majithiya","year":"2006","unstructured":"Majithiya JB, Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci. 2006;78(22):2615\u201324.","journal-title":"Life Sci"},{"issue":"6","key":"10460_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2337\/db20-1157","volume":"70","author":"H Qu","year":"2021","unstructured":"Qu H, Gong X, Liu X, Zhang R, Wang Y, Huang B, et al. Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase exacerbates podocyte injury and the progression of diabetic kidney disease. Diabetes. 2021;70(6):1372\u201387.","journal-title":"Diabetes"},{"issue":"9","key":"10460_CR22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41590-019-0453-7","volume":"20","author":"PK Langston","year":"2019","unstructured":"Langston PK, Nambu A. Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat Immunol. 2019;20(9):1186\u201395.","journal-title":"Nat Immunol"},{"issue":"3\u20134","key":"10460_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00424-017-1950-x","volume":"469","author":"A Justin Rucker","year":"2017","unstructured":"Justin Rucker A, Crowley SD. The role of macrophages in hypertension and its complications. Pflugers Arch. 2017;469(3\u20134):419\u201330.","journal-title":"Pflugers Arch"},{"issue":"1","key":"10460_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ki.2011.29","volume":"80","author":"A Zhang","year":"2011","unstructured":"Zhang A, Jia Z, Wang N, Tidwell TJ, Yang T. Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int. 2011;80(1):51\u201360.","journal-title":"Kidney Int"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-023-10460-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:54:19Z","timestamp":1719921259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-023-10460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10460"],"URL":"https:\/\/doi.org\/10.1007\/s12265-023-10460-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.12.23288119","asserted-by":"object"}]},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The used GWAS data were publicly available and approved by their corresponding institutions. An ethics approval for the current work is not required. No animal subjects were used in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}